참고문헌
- Afsar CU, Gunaldi M, Kum P, et al (2014). Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey. Asian Pac J Cancer Prev, 15, 9143-6. https://doi.org/10.7314/APJCP.2014.15.21.9143
- Andreadis D, Epivatianos A, Poulopoulos A et al (2006). Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol, 42, 57-65.
- Cumhur Cure M, Cure E, Yuce S, Yazici T, Karakoyun I, Efe H (2014). Mean platelet volume and vitamin D level. Ann Lab Med, 34, 98-103. https://doi.org/10.3343/alm.2014.34.2.98
- d'Auriol L, Mattei MG, Andre C, Galibert F (1988). Localization of the human c-kit protooncogene on the q11-q12 region of chromosome 4. Hum Genet, 78, 374-6. https://doi.org/10.1007/BF00291740
- Ding J, Li XM, Liu SL, Zhang Y, Li T (2014). Overexpression of platelet-derived growth factor-D as a poor prognosticator in endometrial cancer. Asian Pac J Cancer Prev, 15, 3741-5. https://doi.org/10.7314/APJCP.2014.15.8.3741
- Dossus L, Lukanova A, Rinaldi S et al (2013). Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. Am J Epidemiol, 177, 787-99. https://doi.org/10.1093/aje/kws309
- Elmore LW, Domson K, Moore JR, Kornstein M, Burks RT (2001). Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Arch Pathol Lab Med, 125, 146-51.
-
Jansson S, Bendahl PO, Grabau DA et al (2014). The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFR
${\alpha}$ , closely spaced at 4q12, show increased protein expression in triple-negative breast cancer. PLoS One, 9, 102176. https://doi.org/10.1371/journal.pone.0102176 - Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G (1994). Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res, 54, 3049-53.
- Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C (1994). Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem, 42, 1417-25. https://doi.org/10.1177/42.11.7523489
- Linkov F, Edwards R, Balk J et al (2008). Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer, 44, 1632-44. https://doi.org/10.1016/j.ejca.2008.05.001
- Matowicka-Karna J, Kamocki Z, Polinska B, Osada J, Kemona H (2013). Platelets and inflammatory markers in patients with gastric cancer. Clin Dev Immunol, 2013, 401623.
- Menczer J, Kravtsov V, Levy T, et al (2005). Expression of c-kit in uterine carcinosarcoma. Gynecol Oncol, 96, 210-5. https://doi.org/10.1016/j.ygyno.2004.09.045
- Miettinen M, Lasota J (2005). KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol, 13, 205-20. https://doi.org/10.1097/01.pai.0000173054.83414.22
- Natali PG, Berlingieri MT, Nicotra MR et al (1995). Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res, 55, 1787-91.
- Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A (1992). Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res, 52, 6139-43.
- Oge T, Yalcin OT, Ozalp SS, Isikci T (2013). Platelet volume as a parameter for platelet activation in patients with endometrial cancer. J Obstet Gynaecol, 33, 301-4. https://doi.org/10.3109/01443615.2012.758089
- Park Y, Schoene N, Harris W (2002). Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets, 13, 301-6. https://doi.org/10.1080/095371002220148332
- Salomonsson A, Jonsson M, Isaksson S et al (2013). Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma. Genes Chromosomes Cancer, 52, 1088-96. https://doi.org/10.1002/gcc.22103
- Scobie JV, Acs G, Bandera CA et al (2003). C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance. Int J Gynecol Pathol, 22, 149-55. https://doi.org/10.1097/00004347-200304000-00006
- Terada T (2012). Protein expression and gene mutation status of KIT and PDGFRA in renal cell carcinoma. Histol Histopathol, 27, 297-302.
- Trinh DT, Shibata K, Hirosawa T et al (2012). Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary. J Obstet Gynaecol Res, 38, 841-8. https://doi.org/10.1111/j.1447-0756.2011.01798.x
- Varol E, Ozaydin M (2014). Confounding factors should be considered in mean platelet volume evaluation in endometrial cancer. J Obstet Gynaecol, 34, 455. https://doi.org/10.3109/01443615.2013.874985
- Wang Y, Qiu H, Hu W, Li S, Yu J (2014). Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer. Int J Mol Sci, 15, 4780-94. https://doi.org/10.3390/ijms15034780
- Weigel MT, Ghazoui Z, Dunbier A, et al (2012). Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer. Breast Cancer Res, 14, 78. https://doi.org/10.1186/bcr3191
- Xiao H, Wang J, Liu Y, Li L (2014). Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer. Oncol Lett, 8, 582-8. https://doi.org/10.3892/ol.2014.2173
- Yarden Y, Kuang WJ, Yang-Feng T et al (1987). Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J, 6, 3341-51.
- Yilmaz E, Celik O, Simsek Y et al (2012). c-Kit proto-oncogene expression in endometrial hyperplasia and endometrial cancer. Arch Gynecol Obstet, 286, 197-200. https://doi.org/10.1007/s00404-012-2276-8
- Zhu Y, Wang Y, Guan B et al (2014). C-kit and PDGFRA gene mutations in triple negative breast cancer. Int J Clin Exp Pathol, 7, 4280-5.
피인용 문헌
- Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis vol.27, pp.8, 2016, https://doi.org/10.3109/09537104.2016.1169265